Table 2.
Substances involved in cases reported to CPCS where ECMO was discussed
| Substances* | N | |
|---|---|---|
| Cardiovascular drugs | 51 | |
| Beta blockers | 14 | |
| Diltiazem | 7 | |
| Verapamil | 7 | |
| Amlodipine | 6 | |
| Flecainide | 6 | |
| ACE/ARB | 4 | |
| Digoxin | 3 | |
| Clonidine | 2 | |
| Diuretics | 2 | |
| Hydrocarbons | 34 | |
| SSRI/SNRI | 9 | |
| Plants | 8 | |
| Analgesics | 7 | |
| Benzodiazepines | 7 | |
| Stimulants | 6 | |
| Opioids | 6 | |
| Caustics | 5 | |
| Ethanol | 5 | |
| Antipsychotics | 4 | |
| Tricyclic Antidepressants | 3 | |
| Anticonvulsants | 2 | |
| Colchicine | 2 | |
| Arsenic | 1 | |
| Baclofen | 1 | |
| Bupivacaine | 1 | |
| Carbon monoxide | 1 | |
| Cyanide | 1 | |
| Glyburide | 1 | |
| Pentobarbital | 1 | |
| Quinine | 1 | |
| Warfarin | 1 | |
| White phosphorous | 1 | |
| Total** | 159 | |
*Most substances were by report and not laboratory confirmation
**Total is greater than 94 since multiple substances can be reported in each case